Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis

Cell Mol Life Sci. 2019 Nov;76(21):4275-4289. doi: 10.1007/s00018-019-03222-1. Epub 2019 Jul 15.

Abstract

Numerous studies have shown that non-coding RNAs play crucial roles in the development and progression of various tumor cells. Plasmacytoma variant translocation 1 (PVT1) mainly encodes a long non-coding RNA (lncRNA) and is located on chromosome 8q24.21, which constitutes a fragile site for genetic aberrations. PVT1 is well-known for its interaction with its neighbor MYC, which is a qualified oncogene that plays a vital role in tumorigenesis. In the past several decades, increasing attention has been paid to the interaction mechanism between PVT1 and MYC, which will benefit the clinical treatment and prognosis of patients. In this review, we summarize the coamplification of PVT1 and MYC in cancer, the positive feedback mechanism, and the latest promoter competition mechanism of PVT1 and MYC, as well as how PVT1 participates in the downstream signaling pathway of c-Myc by regulating key molecules. We also briefly describe the treatment prospects and research directions of PVT1 and MYC.

Keywords: Enhancer; Gene fusion; MYC; PVT1; Positive feedback; Promoter.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics*
  • Carcinogenesis / metabolism
  • Carcinogenesis / pathology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Oncogenes
  • Protein Binding / physiology
  • Proto-Oncogene Proteins c-myc / metabolism*
  • RNA, Long Noncoding / metabolism*
  • Signal Transduction / genetics

Substances

  • MYC protein, human
  • PVT1 long-non-coding RNA, human
  • Proto-Oncogene Proteins c-myc
  • RNA, Long Noncoding